All storiesEmerging therapies

Clinical Support Tool Helps Primary Care Health Professionals Detect and Treat Chronic Kidney Disease

New research presented at ASN Kidney Week 2026 introduces a clinical decision support tool designed to aid primary care providers in diagnosing and managing chronic kidney disease, aiming to improve patient care at the point of service.

NeoMD Editors · 2026-10-23 · 02:41 AM EDT

For information, not personal medical advice. Discuss treatment decisions with a qualified clinician.

The quick read

Key takeaways

A new clinical decision support tool helps primary care providers detect and manage chronic kidney disease (CKD) by offering timely diagnostic and treatment guidance during patient visits.
The tool has been validated for accuracy and usefulness in clinical settings, as presented at ASN Kidney Week 2026, though detailed study methods and outcomes are not provided.
There is no clear evidence yet that using the tool improves long-term patient health outcomes; its real-world impact may vary and requires further study.

Editorial illustration for Clinical Support Tool Helps Primary Care Health Professionals Detect and Treat Chronic Kidney Disease — AI-generated editorial illustration.

Chronic kidney disease (CKD) is a common condition that often remains undiagnosed or undertreated in primary care settings. Early detection and proper management are crucial for slowing its progression and reducing complications.

What the new tool does

Researchers have developed a clinical decision support tool that integrates into primary care workflows. This tool assists healthcare providers by offering timely guidance on diagnosing CKD and recommending appropriate treatment steps. The goal is to improve decision-making during patient visits, leading to earlier identification and better management of CKD.

Evidence and validation

Supporting editorial illustration for Clinical Support Tool Helps Primary Care Health Professionals Detect and Treat Chronic Kidney Disease — AI-generated editorial illustration.

The tool has been validated through research presented at ASN Kidney Week 2026. Validation indicates that it has been tested for accuracy and usefulness in clinical settings. However, the available information does not detail the specific methods, participant numbers, or outcomes measures used to assess its effectiveness.

Limitations and unknowns

While the tool shows promise, the information presented does not clarify whether its use directly leads to improved long-term health outcomes for patients with CKD, such as slowed disease progression or reduced kidney failure rates. The research was conducted in controlled conditions, and real-world benefits may vary depending on how widely and effectively the tool is implemented.

Possible implications

If widely adopted, this decision support tool could support primary care providers in recognizing CKD earlier and managing it more effectively, potentially leading to better patient outcomes. However, further studies are needed to confirm the impact on clinical results and to assess how it performs across diverse healthcare settings.

Source: Medical Xpress